LRCX

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

-0.55%

Status

scored

Maintain LRCX at current exposure with ≤1.5x benchmark weight and 1.85 beta; do not add at $320 despite strong Q2 fundamentals (65.1% ROE, $1.85B net cash, 37.4% operating margins) because the 26% post-print selloff, DSO ambiguity, rich 27x forward P/E, and 96%-no-cut macro create asymmetric risk; scale-in zone is $310 (50 SMA) with $326.63 breakout confirmation required, hard stop at $252, and mandatory 4-5% put hedge through Q3 FY26 earnings in late January 2027.

Outcome

✓

Return

-2.71%

Status

scored

Maintain LRCX at Hold with the $329.51 price having already absorbed the 10/05 trim prescription (correcting from $347 to $329, closer to the 50 SMA at $308.65), with all three risk analysts converging on Hold. The structural bid is winning per the 9/18 lesson with ROE 65%, net cash, and sold-out backlog intact, while cash flow concerns (FCF -47% YoY, DSO extending, buyback cut) prevent upgrading to Overweight. Set bullish trigger at confirmed close >$347.49 on volume >8M with RSI >60, and bearish trigger at confirmed close <$308.65; hedge multiple-compression risk via SPX/SOX puts or 4-5% of position in 3-6 month $300 LRCX puts, with Q3'26 earnings as the binary tell for FCF recovery versus AR extension.

Outcome

✓

Return

-1.31%

Status

scored

Trim 30-40% of LRCX exposure at current ~$333-334 levels while preserving 60-70% core position, as the tape shows confirmed distribution with overhead supply at $347-350. Re-entry conditions include a pullback to the $290-300 zone with a stop below $276, or a confirmed close above $358 on volume exceeding 10M shares, with mandatory reassessment following the Q1 FY27 earnings print in late October.

Outcome

✓

Return

-3.44%

Status

scored

Maintain LRCX at HOLD with 2% portfolio weight and no action at $345.80, as the parabolic 33% rally in 13 days with declining volume (8.70M → 6.05M) and 2.9% gap to upper Bollinger Band at $355.91 mirrors the 10/02 setup that cost -1.2% alpha when Overweight was assigned at similar extension. The structural franchise thesis (ROE 65%, $1.85B net cash, sold-out backlog) forecloses Underweight per the 9/18 binding lesson, but disciplined re-engagement zones at $326, $315-320, and confirmed >$356 breakout with volume capture both the bull case and tactical caution.

Outcome

✗

Return

-0.49%

Status

scored

Initiate/increase LRCX exposure via a 50/50 scale-in structure at $347.50 (first tranche) and $322 limit (second tranche), targeting 1.75% combined position with a $295 hard stop. The Overweight rating reflects the structural-bid franchise case (record Q3 FY26 results: $6.72B revenue, 65.1% ROE, sold-out backlog) delivered through a volume-conscious execution architecture that avoids chasing the upper Bollinger Band at $350.48 into overhead supply at $350-360 ahead of the binary Oct 22-29 earnings catalyst.

Outcome

✓

Return

+2.17%

Status

scored

Maintain LRCX at 2% portfolio weight (mid-band) with no trim at $340, structural stop at $300, and a price target of $343 over a 30-45 day horizon into late-October FY27 Q1 earnings. The HOLD rating reflects a balanced risk-reward of approximately 1.2:1 given the stock is at the upper Bollinger Band and 24% above the 200 SMA with a 52% volume deficit, though the structural-bid franchise quality and constructive momentum justify maintaining mid-band sizing rather than reducing exposure.

Outcome

✓

Return

+3.53%

Status

scored

LRCX maintained at HOLD with unanimous analyst consensus, citing a structural-bid franchise thesis (65.1% ROE, $1.85B net cash, sold-out backlog) that forecloses Underweight, but forward EPS math (28x P/E requiring ~104% normalization) and hostile macro (10Y at 5.14%) that forecloses aggressive positioning. Execution refinements include a tightened $300 stop (2 ATR discipline), reduced 1% portfolio sizing (lower end of 1-2% band), and late-October FY27 Q1 earnings as binary tell on OCF recovery trajectory.

Outcome

✓

Return

+1.44%

Status

scored

Maintain LRCX at HOLD with full position size at $323 as the only calibrated response that honors the binding lesson stack. No distribution triggers have fired (MACD expanding positive at +4.54, no negative divergence), and price is below the $330-340 pre-committed trim zone. Pre-commit to 15-20% trim upon price reaching $330-340 without breakout confirmation OR any confirmed distribution signal firing; hard stop at $297 close with $283 structural-break exit. Reassess after late-October earnings as the binary tell on OCF recovery, buyback resumption, and 2027 WFE commentary.

Outcome

✓

Return

+2.99%

Status

scored

Maintain LRCX at $335 with Hold rating despite acknowledged bearish signals (A/R +58% YoY vs revenue +30%, capital return program drawing down cash, hostile macro with 10Y at 5.14%). The binding 9/24 and 9/25 lessons require confirmed distribution signals before any trim—negative MACD divergence, expanding volume on red sessions, or post-earnings re-pricing—not price extension alone. Protective puts at $280 strike for January 2026 remain in place with hard stop at $255; upgrade to Overweight only on confirmed close above $343 with volume exceeding 15M shares.

Outcome

✓

Return

-0.23%

Status

scored

Analysts maintain LRCX at HOLD with a $315 price target and 30-45 day horizon into Q1 FY27 earnings. The decision balances an exceptional structural franchise (65% ROE, $1.85B net cash, sold-out backlog) against poor entry conditions (27x forward P/E on heroic 104% EPS normalization, 5.14% 10Y yield, 15:1 bullish sentiment extremes). Add zones are set at $260-285 on working-capital stabilization, 10Y below 4.75%, or Q1 FY27 earnings confirmation, with stops at $287.80 and structural break at $269 on volume.

Outcome

✓

Return

+2.62%

Status

scored

Maintain LRCX at Hold with pre-committed 20-25% trim at the $330-340 upper-third zone, refined breakout add-trigger at $315 with above-average volume and flattening 50 SMA, and hard stop at $269 closing basis on expanding volume (200 SMA structural break). Avoid fresh adds until either confirmed breakout above $315 or pullback into $269-280 with working-capital stabilization and macro confirmation. Q1 FY27 earnings (late October/early November 2026) is the binary cycle tell on receivables trajectory and forward EPS revisions.

Outcome

✓

Return

-0.04%

Status

scored

Maintain LRCX at HOLD with a pre-committed 20-25% trim trigger if price reaches the $330-340 upper-third zone; avoid adding at $305-310 and wait for a $269-280 pullback on healthy volume with working capital stabilization before considering new positions. Hard stop at $269 closing basis on expanding volume as the 200 SMA structural break confirmation.

Outcome

✓

Return

-1.18%

Status

scored

Maintain full position in LRCX with HOLD rating as the structural-bid defense has been demonstrably winning after reclaiming the 50 SMA with positive MACD histogram, overriding the Research Manager's Underweight and Trader's Sell proposals. A hard stop at $269 (200 SMA structural break) protects against downside while Trigger A upgrade to Overweight is activated on confirmed close above $343.84 on volume 1.5x average; Q3 earnings in late October/early November serves as the binary cycle tell on the receivables/demand question.

Outcome

✓

Return

+2.87%

Status

scored

Maintain LRCX at current weight (1-1.5% account risk ceiling) without adding at the $302-307 zone, as the 50 SMA rejection pattern (three prior failures in 11 weeks) and binary Q3 FY27 earnings catalyst (late October) preclude aggressive positioning despite structural bid strength (19.6M share reversal, 65% ROE, $1.85B net cash, reclaimed 200 SMA with ~13% buffer). Upgrade to Overweight on confirmed close >$307 with volume >12M and MACD histogram crossing positive; downgrade to Underweight on close below $286 on expanding volume; hard exit at $250.

Outcome

✗

Return

+4.92%

Status

scored

Trim LRCX to approximately 50% of benchmark neutral weight at around $288, capturing the asymmetric risk/reward of -31% downside versus +21% upside while preserving structural-bid participation. The residual position has defined exit triggers at $307 (stop loss on 50 SMA reclaim with volume) and $250 (hard exit on structural breakdown), with re-engagement triggers at $200-250 on capitulation or $307 on confirmed breakout. The Q1 FY27 earnings in late October/early November 2026 serves as the binary cycle catalyst for reassessment.

Outcome

✗

Return

+6.98%

Status

scored

Maintain LRCX at neutral weight (3-5% of portfolio) with no fresh buying at $269.31 levels, as the technical stack is unambiguously broken (price below all major MAs, RSI 36, negative MACD with widening histogram) and the macro stack caps multiple expansion; hard stop at $250 on a closing basis, with a conditional add of 30-40% on confirmed close above $285 with RSI > 45 and rising MACD, and a trim of 50% on close below $264 with elevated volume.

Outcome

✓

Return

+0.03%

Status

scored

Maintain LRCX at current weight with no fresh buying or aggressive trimming, as structural quality (ROE 65%, gross margins at 4-year high of 50.5%, $1.84B net cash, sold-out through 2026) supports continued ownership but cyclical timing risk (forward EPS of $11.65 implies +72-81% growth versus all-time peak of +33%) and hostile macro stack (Fed hiked Sep 16, 95% probability of zero cuts in 2026, recession odds +50%) preclude aggressive accumulation.

Outcome

✓

Return

-0.61%

Status

scored

Maintain LRCX at 85-90% benchmark weight (modest underweight) with a $250 hard stop on a closing basis. Technical triggers for re-engagement include a close above $293 on above-average volume for Overweight, or a flush to $240-250 with RSI sub-30 and capitulation volume for Buy. The $320 price target assumes technical recovery, while the $221 bear case applies 19x multiple compression on consensus EPS in a 5% yield regime.

Outcome

–

Return

-0.96%

Status

scored

Reduce LRCX to Underweight via a hybrid trim strategy—10-15% reduction at current prices plus 15-20% contingent on a relief rally into the $285-$295 zone—while maintaining a hard stop at $264.60 daily close on the remainder. The rating reflects three consecutive failed Hold setups on high-beta setups, requiring meaningful underweight (25-40% trim) rather than cosmetic positioning; re-engagement requires a confirmed close above $299 on volume greater than 15M with a positive MACD histogram.

Outcome

✗

Return

-8.29%

Status

scored

Maintain LRCX at 90% benchmark weight (slight underweight) with a collar hedge structure (sell $320-325 calls, buy $280-285 puts, 3-month tenor) to neutralize FOMC binary risk, with mechanical stop at $260 (200 SMA) and re-engagement triggers at $314 close on 1.5x volume with MACD zero-line crossover. The HOLD rating reflects convergence that the structural bull thesis (30% revenue growth, 65% ROE, $5.58B cash, rising deferred revenue) remains intact but the broken technical stack (price below both 10 EMA and 50 SMA, MACD at -3.95) justifies the modest underweight rather than full benchmark exposure or aggressive trimming.

Outcome

✓

Return

+0.07%

Status

scored

Maintain LRCX at HOLD with a defensive posture anchored by a hard stop at $285 (closing basis, below lower Bollinger band) while preserving upside optionality through a refined three-tier scaling-in framework—first add at $316 close with volume >12M, second add at $325 after $316 retests as support, and third add at $342 with MACD expanding positive and price above rising 10 EMA. A partial hedge via 30-40% position coverage in 3-month $280 puts is recommended to cap binary catalyst risk ahead of Q3 FY26 earnings, with weekly reassessment and a 3-6 month time horizon.

Outcome

✗

Return

-5.65%

Status

scored

Maintain LRCX at HOLD with no new capital deployment at ~$315; trim 25-33% into the $325-335 zone (50 SMA retest) and add only on a confirmed daily close above $345 with volume >7M shares and stable forward EPS >$11.50. Hard stop at $278 closing basis; keep weighting below 2x benchmark given 1.859 beta and tightening macro backdrop (93% no-cut probability, $100 oil, expanding term premium).

Outcome

✓

Return

-1.43%

Status

scored

Maintain HOLD on LRCX at $320.42 with no fresh capital deployment. The 50 SMA at $320.71 is unconfirmed as resistance-turned-support, and three prior reflections (9/2 Underweight, 9/4 HOLD +4.7%, 9/3 HOLD +5.5%) converge against directional change. Tighten stop to $295 and set mechanical re-engagement triggers at $325 breakout (8M+ shares) and $306-$313 pullback with MACD confirmation.

Outcome

✗

Return

+4.15%

Status

scored

Maintain LRCX at Hold with no new capital deployment and no trimming at $307.65. Key entry triggers preserved at $321.88 (8.5M+ volume confirmation) and Q3'26 fundamental validation (FCF/net income >60%). Hard stop at $292.66 daily close; thesis invalidation at $258 weekly close below 200 SMA. The decision threads the needle between aggressive scaling-in risk and conservative trim-into-strength failure modes documented in prior reflections.

Outcome

✗

Return

+5.12%

Status

scored

Maintain LRCX at HOLD with no fresh capital deployment; the setup shows LRCX trading 11% above the $259.88 200 SMA with gross margins at 51.8% and forward EPS of $11.57, but price remains below all major moving averages with RSI 42 not oversold and MACD bearish. Hard stop placed at $275 on a closing basis (below recent swing lows and lower Bollinger Band), with thesis invalidation at $258 on 200 SMA break; re-engagement requires either 200 SMA test with $300 reclaim on volume or 50 SMA reclaim at $323.77 with volume.

Outcome

✗

Return

+1.51%

Status

scored

Trim LRCX 40–50% at $288 prevailing within 1–3 sessions to reach 50–60% of benchmark weight, with hard stop at $258 on confirmed daily close above 9.5M volume; thesis invalidated on weekly close below $252. Re-engagement requires 3 of 4 confirmations (defended 200 SMA, buyback resumption ≥$500M/quarter, AR/revenue ratio <1.5x, MACD positive + price reclaims 10 EMA at $305). Post-trim sizing capped at ≤2–3% NAV with 10–15% put hedge (60–90 day $260–270 strikes) through Q1 FY27 earnings as binary catalyst.

Outcome

✓

Return

-0.65%

Status

scored

Trim 25% of LRCX via staged sales above $295 over 5-10 sessions, retaining 75% core for the AI capex thesis while setting a hard stop at $256 (below 200 SMA). Re-engage on close above $309 with >9.5M shares volume, with Q1 FY27 earnings as the binary cycle tell on whether AR growth normalizes below 1.5x revenue growth, supporting a move toward Hold or Overweight versus further Underweight degradation.

Outcome

✗

Return

-3.74%

Status

scored

Maintain LRCX at Hold with no fresh capital deployment or trimming, anchoring to the 8/26 binding reflection that Hold outperforms token trims on this setup. Tighten the working stop to $258 daily close and set thesis invalidation at $252 weekly close on 200 SMA break, compressing the buffer that caused the prior Hold to bleed -5.0%. Re-engagement triggers include either a defended 200 SMA test with RSI divergence/volume confirmation or a clean 10 EMA reclaim at $313 on >50M shares with RSI >50 and positive MACD histogram, sized at ≤2-3% NAV given the 1.865 beta.

Outcome

–

Return

-0.14%

Status

scored

Analysts recommend trimming 25-30% of LRCX exposure via staged sales into the $315-320 zone over 1-2 weeks while retaining a 70-75% core position, citing a confluence of broken technicals (price below 10 EMA, 50 SMA, and VWMA), elevated TTM P/E of 52x, hawkish Polymarket repricing (~1% September cut probability, ~10% December), and a receivables surge from $3.49B to $5.34B (now ~23% of sales) as late-cycle warning flags. The stop is tightened to $270-275, with re-engagement triggers at $331 reclaim or $252-257 retest, and Q3 FY26 earnings in late October serves as the binary catalyst to resolve the cycle debate.

Outcome

✗

Return

-5.24%

Status

scored

Maintain LRCX at ≤3% risk-adjusted exposure cap with no fresh capital deployment ahead of three clustered binary catalysts (Jackson Hole Aug 28, Q3 FY26 late October, hyperscaler 2027 capex commentary). The structural bull case (65.1% ROE, $6.1B FCF, $1.86B net cash, deferred revenue rising, 200 SMA intact) and the cycle-timing bear case (AR+58% vs revenue+30%, beta 1.87, elevated inventory at 67 days, broken 50 SMA at $332.65) cancel out cleanly, making Hold the appropriate stance that captures both without inheriting directional error.

Outcome

✗

Return

+1.82%

Status

scored

Trim 10-15% of LRCX exposure ahead of the Jackson Hole symposium (Aug 28) to reduce beta exposure in an asymmetric catalyst window, while retaining an 85-90% core position for the structural thesis; hard stop at $280 with add-back triggered on a volume-confirmed close above $341 at ≥1.5x 20-day average. The 10-15% trim magnitude balances the 8/25 reflection (which instructed action over passive Hold) against the 8/24 lesson (which counseled against overshooting on high-quality compounders), with Q3 FY26 earnings in late October serving as the binary cycle tell.

Outcome

✓

Return

-0.57%

Status

scored

Maintain LRCX with disciplined 1-2% NAV sizing and a hard stop at $270, avoiding new capital deployment at current $315 levels despite intact structural bull case (30% revenue growth, 65% ROE, $1.85B net cash). The HOLD balances strong fundamentals against hostile macro (86% no-cut odds), unconfirmed technicals, and deteriorating cash conversion (AR +58% vs revenue +30%), preserving optionality without committing capital into unconfirmed resistance. Q3 FY26 earnings (late October 2026) is the single binary catalyst for re-evaluation.

Outcome

✗

Return

+1.45%

Status

scored

Trim 30-35% of LRCX exposure at $310-320 rather than waiting for a $336 relief rally, maintaining a 50-60% core position with a hard stop at $245 ($5 below the July 29 capitulation low of $250.50). Consider a 10-15% short-dated put hedge through Aug 28 to cover binary catalyst risk from NVDA earnings and Jackson Hole. Re-engage to full weight only after mid-September once these catalysts resolve and the technical picture clarifies.

Outcome

✓

Return

-1.22%

Status

scored

Trim 30-40% of LRCX exposure on relief rallies into the $320-330 zone, retaining a 50-60% core. The MACD histogram has rolled from positive basing (+6.48) to momentum failure (+2.21), the 50 SMA has transitioned from flattening to actively declining, and the Q2 buyback collapse of 68% signals near-term risk that the market isn't pricing. Hard stop $282-285 on remaining position; re-engagement only on 50 SMA reclaim with volume >10M and RSI >60, or constructive 200 SMA retest with bullish price action.

Outcome

–

Return

+1.12%

Status

scored

Trim LRCX to 70% of benchmark weight (or 50-60% if overweight) given peak-cycle vulnerability at 27x forward P/E, as semi equipment cycle timing and macro headwinds (86% probability of no Fed cuts in 2026) create ~1:2.2 risk-reward asymmetry favoring bears. Re-enter on either a pullback to $220-240 with P/E below 20x or a clean break above $360 on heavy volume; full sell requires decisive close above $390 on >15M shares.

Outcome

✓

Return

+1.09%

Status

scored

Maintain LRCX exposure at current weight without deploying new capital at current levels; trim 20-30% into the $318-328 rally and take an additional third off at $337. The Q3 FY26 earnings print (mid-to-late October 2026) is the binary cycle tell for re-evaluation, with a hard stop at $278 on the remaining position and no new capital deployment below $337.74 without volume-confirmed breakout above the 50 SMA.

Outcome

✗

Return

-6.33%

Status

scored

Initiate a phased overweight position in LRCX starting with 0.75–1.0% allocation near $327.92 as a structural bull case trade, with hard stop at $294 and second tranche entry conditional on either a confirmed close above $352.51 with volume exceeding 12M shares or a successful retest of the $305–$314 support zone with reversal candle. Hedge via a 6–9 month $350 call overlay per the neutral analyst framework, trim one-third into the $410–$415 target zone and another third at the $438 ATH, with mandatory reassessment at Q1 FY27 earnings in late October/early November 2026.

Outcome

✓

Return

-4.63%

Status

scored

Trim LRCX by 30-40% across two tranches while maintaining a 60-75% core, as structural quality remains intact but near-term risks in cash conversion (OCF fell 43% YoY to $1.46B), stretched valuation at ~30x forward earnings, and elevated macro headwinds (30-year yields at 19-year highs, 1.87 beta) outweigh upside potential until entry triggers are met or weakness near $280-$300 emerges; hard invalidation occurs on a decisive close above $390 on more than 15M shares, with mandatory reassessment at the October earnings catalyst.

Outcome

–

Return

+3.45%

Status

scored

Analyst maintains a measured Underweight on LRCX, recommending a ~30% trim in tranches into the $337–$345 resistance zone while retaining a 60–70% core position; a daily-close stop at $317.76 is set, with no new capital added before either a volume-confirmed break above $346.52 with MACD confirmation or a pullback to $300–$310.

Outcome

✓

Return

-1.38%

Status

scored

Maintain LRCX at ~$337 with a HOLD rating pending either a confirmed breakout above $345 on volume >12M shares or a pullback to the $290–$305 zone. The position should be trimmed on a daily close below $290, with Q1 FY27 earnings in late October serving as the decisive cycle re-evaluation catalyst. Entry sizing should remain ≤30% of target weight until confirmation materializes.

Outcome

✓

Return

+3.34%

Status

scored

Maintain LRCX exposure at Hold; fundamentals are cycle-best with record revenue ($6.72B), 65.1% ROE, and visible HBM/3D NAND demand through 2027, but technical setup remains unconfirmed—today's $329.49 rejection at the first resistance level on 7.26M shares (below the 10M+ threshold) argues against adding at current levels. Add trigger is a confirmed close above $341 on >10M shares, with a hard stop at $285 on existing longs and trim trigger at failed retest of $295 on heavy volume.

Outcome

✗

Return

+4.72%

Status

scored

Trim 30-40% of LRCX on rallies into the $325-340 resistance zone while maintaining a reduced core position of ~60% of original size, given the structurally stronger bear case (historical NAND cycle patterns, extreme bullish consensus with 16/20 articles bullish, and earnings quality deterioration with receivables +58% YoY against 26% revenue growth). Full exit is triggered by a weekly close below $246.59 (200 SMA), while a sustained close above $343 with volume >10M shares would warrant re-evaluation back to Hold.

Outcome

✓

Return

+1.64%

Status

scored

Buy LRCX at $302 with a reduced 30% initial tranche to manage risk ahead of the binary AMAT catalyst on Aug 13; stop hard at $282 (tighter than the bear's proposed $278) and scale to 75–100% target only on technical confirmation or post-AMAT clarity. The trade accepts cyclical and event risk but sizes the position to survive without forced exit.

Outcome

✗

Return

-1.59%

Status

scored

Initiate an overweight position through a three-tranche approach: Tranche 1 at 4-5% portfolio on volume-confirmed close >$298.67 VWMA (>7M shares), Tranche 2 at $290-$300 pullback, and Tranche 3 on 50 SMA reclaim above $337.77, scaling to 17-18% total exposure with a $283 hard stop; trim 25% on RSI>75 without SMA reclaim, trim 50% at $390, and trail on close below 21-day EMA; upgrade to full Buy on close >$337.77 with >15M volume and MACD histogram >+5 over a 3-6 month horizon.